Transgene Biotek Ltd Approves Unaudited Consolidated & Stand-alone Financial Results for Q3 2025

Transgene Biotek Ltd has approved the unaudited Consolidated & Stand-alone Financial Results for the quarter ended 31.12.2025. The company's financial results have been prepared in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015. The Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31.12.2025 has also been approved.